Slingshot Biosciences Strengthens UK and EU Presence with Synthetic Cell Mimic Technology

Life sciences innovator and leader in precision-engineered synthetic cell mimic technology expands its UK/EU operations to accelerate cell and gene thera...

February 06, 2026 | Friday | News
10x Genomics Powers UK PharosAI Initiative to Build Multimodal Cancer Dataset

Initiative will create one of the world's largest multimodal cancer datasets and an integrated suite of AI models and tools to fuel p...

February 06, 2026 | Friday | News
QIAGEN CEO Thierry Bernard Highlights Resilient Growth as 2025 Results Beat Outlook and Set Strong 2026 Trajectory

Q4 2025: Net sales of $540 million (+4% at actual rates, +1% at constant exchange rates (CER)); diluted EPS of $0.49 and adjusted diluted EPS of $0.6...

February 06, 2026 | Friday | Company results
Automation, SPE, and Mass Spectrometry: The New Front Line of PFAS Regulation

As regulators worldwide intensify scrutiny of per- and polyfluoroalkyl substances (PFAS), laboratories are being pushed into a new era of sensitivity, sp...

February 04, 2026 | Wednesday | Interaction
Acadia Signals Re-Examination Path After Negative CHMP Trend Vote for Trofinetide

Company expects to receive a negative opinion following oral explanation feedback and intends to request re‑examination upon review of formal adoptio...

February 04, 2026 | Wednesday | News
Illumina Deepens Leadership in Proteomics and Multiomics With Completed SomaLogic Acquisition

Deeply expands leadership in proteomics and multiomics Combined capabilities bring high scalability, flexibility, and affordability into protein an...

February 03, 2026 | Tuesday | News
Ardena Completes Divestment of Södertälje API Site to Nanologica AB

Ardena, a specialist CDMO and bioanalytical CRO enabling precision medicines and other complex therapies, today announced that it has completed the dives...

February 02, 2026 | Monday | News
H.U. Group’s Fujirebio Launches Fully Automated pTau217 CSF Assay for Alzheimer’s Research

H.U. Group Holdings Inc. and its wholly-owned subsidiary Fujirebio announced the availability of the Lumipulse G pTau 217 CSF assay for the fully automat...

January 30, 2026 | Friday | News
Tenpoint Therapeutics Raises $235M in Series B Financing and Credit Facility to Support YUVEZZI Launch

Tenpoint Therapeutics, Ltd., a global, commercial biotechnology company focused on developing groundbreaking treatments to rejuvenate vision in the aging...

January 30, 2026 | Friday | News
SK Capital to Divest Noramco API Assets to Siegfried as Halo Pharma Emerges as Stand-Alone Drug Product CDMO

SK Capital Partners have signed a definitive agreement to divest the Noramco API related assets in a sale to Siegfried (Zofingen Switzerland) The...

January 29, 2026 | Thursday | News
Boehringer Ingelheim’s Apecotrep Delivers 40% Proteinuria Reduction in Phase II Primary FSGS Trial

Apecotrep (BI 764198) is a potential first-in-class, oral, selective TRPC6 inhibitor being investigated as a novel, targeted, non-immunosuppressive the...

January 29, 2026 | Thursday | News
SamanTree Medical Secures €20M EIB Financing to Advance Real-Time Surgical Imaging

SamanTree Medical, a European leader in surgical imaging innovation, has secured €20 million in financing from the European Investment Bank (EIB). T...

January 28, 2026 | Wednesday | News
Roche’s CT-388 Delivers 22.5% Placebo-Adjusted Weight Loss in Phase II Obesity Trial

A once-weekly subcutaneous injection of CT-388 achieved a statistically significant placebo-adjusted weight loss of 22.5% (p < 0.001) at 48 weeks at...

January 28, 2026 | Wednesday | News
Gannet BioChem Acquires Laysan Bio to Expand Activated Polymer and Bioconjugation Capabilities

Gannet BioChem, a leading specialty Contract Development and Manufacturing Organization (CDMO) backed by Boston-based private equity firm Ampersand Capit...

January 28, 2026 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close